Scholar Rock Holding Corp

SRRKNASDAQ · USD
48.61USD-1.24 (-2.49%)
129

Scholar Rock Holding Corp (SRRK) Straddle

SRRK straddle scan found 41 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 52.0%.

Read more

Trading a SRRK straddle lets you take a pure volatility position on Scholar Rock Holding Corp without committing to a direction. Scholar Rock Holding Corp's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate SRRK straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on SRRK profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Scholar Rock Holding Corp stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the SRRK straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis.

The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the SRRK straddle is the cleanest expression of that view. Our scanner prices every SRRK straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a SRRK straddle into a catalyst or short a SRRK straddle to harvest decay, the options straddle setups that matter are all in one place.

Jan 21, 202885.00$43.2048510%52.0%$128.20$41.800
Apr 16, 202780.00$32.9820510%51.8%$112.98$47.030
Jan 15, 202775.00$26.6311410%51.2%$101.63$48.380
Apr 16, 202775.00$28.7520510%51.2%$103.75$46.250
Jan 21, 202880.00$39.6548510%50.9%$119.65$40.350
Jan 15, 202770.00$22.3011410%50.2%$92.30$47.700
Apr 16, 202770.00$24.9520510%50.2%$94.95$45.050
Oct 16, 202660.00$10.602310%49.8%$70.60$49.4029
Jan 21, 202875.00$36.4048510%49.4%$111.40$38.600
Jan 15, 202765.00$18.4011410%49.1%$83.40$46.600

As of September 23, 2026

Find the right straddle before volatility moves

Track SRRK straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial